What Will Be the Impact of the New IPT Consolidation Plan on P&MA in Spain?
In December 2020, the Spanish MoH presented a plan to consolidate Therapeutic Positioning Reports (IPTs) with an aim to formally incorporate health-economic evaluations into these reports (e.g. cost-effectiveness).
| Blog | Healthcare & Life Sciences Pharma & Biotechnology Commercial Strategy & Pricing Consulting